BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan.
Saved in:
| Title: | BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan. |
|---|---|
| Authors: | Goulart Rosa R; Social Responsibility Unit, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil.; Research Unit, Inova Medical, Porto Alegre, RS, Brazil., Spinardi J; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., Allen KE; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., Manfio J; Research Institute, HMV, Porto Alegre, RS, Brazil., de Araujo CLP; Research Institute, HMV, Porto Alegre, RS, Brazil., Cohen M; Research Institute, HMV, Porto Alegre, RS, Brazil., Robinson CC; Research Unit, Inova Medical, Porto Alegre, RS, Brazil., Sganzerla D; Unimed, Porto Alegre, RS, Brazil., Ferreira D; Otus Solutions, Porto Alegre, RS, Brazil., de Souza EM; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil., de Oliveira JC; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil., Gradia DF; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil., Brandalize APC; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil., Kucharski GA; Secretaria Municipal de Saúde de Toledo, Toledo, PR, Brazil., Pedrotti F; Secretaria Municipal de Saúde de Toledo, Toledo, PR, Brazil., Rodrigues CO; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil., Kyaw MH; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., Castillo GDCM; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., Srivastava A; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., McLaughlin JM; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., Falavigna M; Social Responsibility Unit, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil.; Research Unit, Inova Medical, Porto Alegre, RS, Brazil.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. |
| Source: | PloS one [PLoS One] 2022 Oct 20; Vol. 17 (10), pp. e0276384. Date of Electronic Publication: 2022 Oct 20 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial Protocol |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36264905 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Goulart+Rosa+R%22">Goulart Rosa R</searchLink>; Social Responsibility Unit, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil.; Research Unit, Inova Medical, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Spinardi+J%22">Spinardi J</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America.<br /><searchLink fieldCode="AU" term="%22Allen+KE%22">Allen KE</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America.<br /><searchLink fieldCode="AU" term="%22Manfio+J%22">Manfio J</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Araujo+CLP%22">de Araujo CLP</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Cohen+M%22">Cohen M</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Robinson+CC%22">Robinson CC</searchLink>; Research Unit, Inova Medical, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Sganzerla+D%22">Sganzerla D</searchLink>; Unimed, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Ferreira+D%22">Ferreira D</searchLink>; Otus Solutions, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Souza+EM%22">de Souza EM</searchLink>; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Oliveira+JC%22">de Oliveira JC</searchLink>; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil.<br /><searchLink fieldCode="AU" term="%22Gradia+DF%22">Gradia DF</searchLink>; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil.<br /><searchLink fieldCode="AU" term="%22Brandalize+APC%22">Brandalize APC</searchLink>; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil.<br /><searchLink fieldCode="AU" term="%22Kucharski+GA%22">Kucharski GA</searchLink>; Secretaria Municipal de Saúde de Toledo, Toledo, PR, Brazil.<br /><searchLink fieldCode="AU" term="%22Pedrotti+F%22">Pedrotti F</searchLink>; Secretaria Municipal de Saúde de Toledo, Toledo, PR, Brazil.<br /><searchLink fieldCode="AU" term="%22Rodrigues+CO%22">Rodrigues CO</searchLink>; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil.<br /><searchLink fieldCode="AU" term="%22Kyaw+MH%22">Kyaw MH</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America.<br /><searchLink fieldCode="AU" term="%22Castillo+GDCM%22">Castillo GDCM</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America.<br /><searchLink fieldCode="AU" term="%22Srivastava+A%22">Srivastava A</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America.<br /><searchLink fieldCode="AU" term="%22McLaughlin+JM%22">McLaughlin JM</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America.<br /><searchLink fieldCode="AU" term="%22Falavigna+M%22">Falavigna M</searchLink>; Social Responsibility Unit, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil.; Research Unit, Inova Medical, Porto Alegre, RS, Brazil.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2022 Oct 20; Vol. 17 (10), pp. e0276384. <i>Date of Electronic Publication: </i>2022 Oct 20 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial Protocol – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36264905 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0276384 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0276384 Titles: – TitleFull: BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Goulart Rosa R – PersonEntity: Name: NameFull: Spinardi J – PersonEntity: Name: NameFull: Allen KE – PersonEntity: Name: NameFull: Manfio J – PersonEntity: Name: NameFull: de Araujo CLP – PersonEntity: Name: NameFull: Cohen M – PersonEntity: Name: NameFull: Robinson CC – PersonEntity: Name: NameFull: Sganzerla D – PersonEntity: Name: NameFull: Ferreira D – PersonEntity: Name: NameFull: de Souza EM – PersonEntity: Name: NameFull: de Oliveira JC – PersonEntity: Name: NameFull: Gradia DF – PersonEntity: Name: NameFull: Brandalize APC – PersonEntity: Name: NameFull: Kucharski GA – PersonEntity: Name: NameFull: Pedrotti F – PersonEntity: Name: NameFull: Rodrigues CO – PersonEntity: Name: NameFull: Kyaw MH – PersonEntity: Name: NameFull: Castillo GDCM – PersonEntity: Name: NameFull: Srivastava A – PersonEntity: Name: NameFull: McLaughlin JM – PersonEntity: Name: NameFull: Falavigna M IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 10 Text: 2022 Oct 20 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 17 – Type: issue Value: 10 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |